US Patent Family Members and Approved Drugs for Saudi Arabia Patent: 92130214
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Saudi Arabia Patent: SA92130214
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 5,441,868 | 2012-08-15 | epoetin alfa | Amgen, Inc. | EPOGEN/PROCRIT |
| 5,547,933 | 2013-08-20 | epoetin alfa | Amgen, Inc. | EPOGEN/PROCRIT |
| 5,618,698 | 2003-12-13 | darbepoetin alpha | Amgen, Inc. | ARANESP |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
